Allowing Companies

 
News Articles for Allowing Companies top ^
2013/10/8
Voip-Pal.com Inc. (“Voip-Pal”, “Company”) (OTC Pink: VPLM) is pleased to announce that the US Patent and Trademark Office (USPTO) has allowed its patent application “Uninterrupted Transmission of Internet Protocol Transmissions During Endpoint Changes.” Allowance means that prosecution is closed for the patent application and it is allowed for issuance as a patent.
Sign-up for Voip-Pal.com Inc.’s Patent Application for Uninterrupted Transmission for Internet Protocol Receives Allowance for Issuance as a Patent investment picks
2014/1/30
http://media.marketwire.com/attachments/201401/TN-220069_MacBookPro2-High.jpg http://media.marketwire.com/attachments/201401/TN-220070_iPad-High.jpg http://media.marketwire.com/attachments/201207/64160_livedeal-logo1.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1085928&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for LIVE in 60 Seconds or Less: LiveDeal Announces Official Launch of DealCentral, the First Online Deal Portal Allowing Restaurants to Create and Publish Offers in Seconds investment picks
2013/11/19
HALF MOON BAY, Calif., Nov.
Sign-up for Endeavor IP, Inc. Issued a Notice of Allowance From United States Patent and Trademark Office investment picks
Alkermes plc (NASDAQ:ALKS) today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 14/032,736, entitled “Prodrugs of fumarates and their use in treating various diseases.” The allowed composition of matter claims will cover Alkermes’ MMF prodrug, ALKS 8700, a proprietary, small-molecule prodrug of monomethyl fumarate (MMF) for the treatment of multiple sclerosis.
Sign-up for Alkermes Announces Notice of Allowance of U.S. Patent for a Novel Fumarate Prodrug for Multiple Sclerosis investment picks
2013/9/3
Voip-Pal.com Inc. (“Voip-Pal”, “Company”) (OTC Pink:VPLM) is pleased to announce that on August 30, 2013, the US Patent and Trademark Office (USPTO) has allowed its patent application “Mobile Gateway.” Allowance means that prosecution is closed for the Mobile Gateway patent application and it is allowed for issuance as a patent.
Sign-up for Voip-Pal.com Inc.’s Mobile Gateway Patent Application Receives Allowance for Issuance as a Patent investment picks
2014/4/10
http://media.marketwire.com/attachments/201309/66726_horizon.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1105620&ProfileId=051205&sourceType=1 DEERFIELD, IL --
Sign-up for Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets investment picks
Global Water to sale certain agreements that allow for future utility services in the City of Glendale Canada NewsWire PHOENIX, AZ , Sept.
Sign-up for Global Water to sale certain agreements that allow for future utility services in the City of Glendale investment picks
2013/12/11
LONDON , Dec.
Sign-up for GW Pharmaceuticals plc Announces U.S. Patent Allowance for Use of Cannabinoids in Treating Glioma investment picks
Rovi Corporation (NASDAQ: ROVI), a global leader in entertainment discovery, today introduced Rovi Remote Access Services, a new component of its Rovi Cloud Services that are designed to allow service providers and authorized third-party developers to create applications for Smart TVs, phones, and tablets that can control legacy cable set-top boxes.
Sign-up for Rovi Unveils Remote Access Services to Allow Connected Guides to Control Legacy Set-Top Boxes investment picks
2014/2/3
BrainStorm Cell Therapeutics (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it has received a Notice of Allowance from the U.S. Patent Office for its “Mesenchymal Stem Cells for the Treatment of CNS Diseases” (serial number 12/994,761) patent application.
Sign-up for BrainStorm Receives US Notice of Allowance for its Key Stem Cell Technology Patent investment picks
2014/2/14
By Andrew Grossman Federal regulators will allow banks to provide financial services to marijuana-related businesses operating legally under state laws as long as lenders make regular reports to the Treasury Department and watch for suspicious activity.
Sign-up for Banks to be Allowed to do Business With Marijuana Dispensaries investment picks
2013/9/12
Zillow Search Experience is First to Allow Users to Combine Elementary, Middle and High Schools and GreatSchools Ratings All in One Search SEATTLE , Sept.
Sign-up for Zillow Launches New Schools Search Tool; Allows Shoppers to Search in Multiple School Areas Simultaneously investment picks
- Patent valid until at least 2031 - JERUSALEM , Sept.
Sign-up for BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C investment picks
2013/11/5
Launch Partners BoomTown and Zurple to Directly Integrate and Connect with Zillow SEATTLE , Nov.
Sign-up for Zillow Launches Zillow Tech Connect; Allows Brokers and Agents to Easily Use Zillow with Their Current Customer Relationship Management Program investment picks
22nd Century Group, Inc. (OTCBB: XXII ) today announced that the European Patent Office issued a Notice of Grant to the company for the NBB and A622 genes.
Sign-up for European Patent Allowed for 22nd Century’s Nicotine Biosynthesis Genes investment picks
- KB004, experimental anti-EphA3 monoclonal antibody therapeutic, in clinical development against hematologic cancers SOUTH SAN FRANCISCO, Calif.
Sign-up for KaloBios Receives Notice of Allowance for Key Composition of Matter Patent Covering KBOO4 investment picks
2013/12/20
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that it has received a Notice of Allowance from the U.S. Patent Office for application 13/584,317. This application, along with U.S. Patent 8,251,947 granted in August of 2012, relate to Antares’ injector technology for wet-dry injectable drugs such as lyophilized biologicals or peptide drugs that require dry storage to assure stability.
Sign-up for Antares Pharma® Announces Notice of Allowance for New Patent on Reconstitutable Lyophilized Injectables investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Allowing Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Allocation Stock Funds  |  Next: Allowing Consumers